Core Insights - NetEase Cloud Music and Universal Music Group have reached a multi-year licensing agreement, indicating a strategic partnership in the music industry [2] - The licensing agreement comes after the National Copyright Administration encouraged music platforms like NetEase Cloud Music and Tencent Music to share music copyrights, which has altered the competitive landscape [2] - The agreement includes clauses related to artificial intelligence (AI), addressing copyright issues associated with AI-generated music [2] Group 1: Partnership and Licensing - The partnership aims to enhance copyright distribution, artist promotion, AI technology exploration, and cultural exchange [2] - NetEase Cloud Music's monthly active users exceed 200 million, with over 90% of active users being from the post-90s and post-00s generations [2] Group 2: Competitive Landscape - Despite being among the top three music apps in terms of monthly active users, NetEase Cloud Music faces competition from ByteDance's music platform, which ranks fourth [2]

Core Insights - The PwC Global CEO Survey reveals a significant gap between the ambition for AI application and the actual benefits realized by companies, with only 10% to 12% reporting positive impacts on revenue growth or cost control from AI investments [1][4] - Despite a general confidence in the global economy, only 30% of CEOs believe their companies can achieve revenue growth in the next 12 months, marking a decline from 56% in 2022 [5] Group 1: AI Application and Challenges - Companies are transitioning from questioning whether to adopt AI to fully engaging in AI strategies, with no one doubting its value anymore [1] - A staggering 56% of companies report that their AI investments have yielded no returns, aligning with MIT's finding that 95% of generative AI pilot projects fail [1][4] - The root cause of this paradox is not the technology itself but the neglect of foundational elements necessary for successful AI implementation, such as data governance and business process optimization [4] Group 2: CEO Sentiment and Future Outlook - CEO confidence in revenue growth has dropped significantly, with only 30% expressing optimism for the next year, the lowest in five years [5] - Despite declining confidence, many leaders are still pursuing long-term growth opportunities through AI and technological innovation [5] - The current environment presents a significant challenge for leaders, requiring them to adapt quickly and embrace change while moving beyond tactical daily operations [4] Group 3: Workforce Transformation and Leadership - The traditional apprenticeship model is being disrupted by AI, necessitating a redesign of career development paths that focus on system thinking rather than task execution [8] - Companies are encouraged to adopt a long-term perspective, viewing the current investment wave as a precursor to a new era of innovation, similar to past infrastructure booms [8] - Leaders are urged to embrace change and actively seek understanding of emerging challenges, as this proactive approach is essential for navigating the evolving landscape [8]

Core Insights - Artificial Intelligence (AI) is accelerating drug development globally, highlighting the increasing interdependence between China and the United States [1][3] - The competitive advantage in AI-driven drug development relies not only on computational power but also on the ability to efficiently extract data from genomics and clinical trials, with China emerging as a significant data source for the U.S. [1][3] Group 1: AI in Drug Development - The first step in building effective AI models for drug development is data collection, which involves integrating dispersed data from various countries [3] - U.S. pharmaceutical companies heavily rely on Chinese clinical data to support AI model training and drug development [3] - China's clinical trial ecosystem is considered one of the best globally, characterized by a large patient base and rapid recruitment speeds [3] Group 2: Market Dynamics and Collaborations - In 2025, Chinese pharmaceutical companies completed 157 early drug licensing agreements totaling $135.7 billion, primarily with large Western pharmaceutical firms [4] - Notable collaborations include a $5.6 billion exclusive licensing agreement between Rongchang Biotech and AbbVie for a new PD-1/VEGF dual-target antibody drug [4] - Chinese biotech firms are leveraging partnerships with multinational companies to access international markets, as seen in the collaboration between Takeda Pharmaceutical and Innovent Biologics, valued at $11.4 billion [4] Group 3: Challenges and Future Outlook - Despite advancements, U.S. remains a leader in AI-driven drug development due to superior AI technology and a mature venture capital ecosystem [5] - The U.S. is tightening control over biological data, with recent legislation seen as a strategic move to limit collaboration with Chinese biotech firms [5] - The global pharmaceutical industry is transitioning from serendipitous drug discovery to hypothesis-driven models supported by AI, with automated laboratories capable of conducting thousands of experiments daily [5] Group 4: Growth Projections for AI in Pharmaceuticals - The global AI pharmaceutical market is projected to reach $5.62 billion by 2028, with long-term estimates ranging from $28 billion to $53 billion [6] - In China, the AI pharmaceutical sector is expected to experience rapid growth, with market size anticipated to exceed 500 billion RMB by 2030, maintaining a compound annual growth rate of over 15% [6]

《大空头》原型人物迈克尔・伯里（Michael Burry）在反对人工智能（AI）炒作的战斗中找到了意想不到的同道中人："蝙蝠侠"的扮演 者之一本・阿弗莱克（Ben Affleck）。 这位好莱坞影星在最新一期《乔・罗根访谈录》播客节目中直言，他与这位传奇投资者一样，对人工智能领域的夸大宣传，以及科技巨 头在这项新兴技术上的巨额投资感到质疑。 "我觉得这类论调大多出自那些急于为公司估值正名的人之口，他们会说：'两年内我们将颠覆一切，以后再也不用工作了。'"阿弗莱克说 道。 他补充道："他们这么说的原因很简单，就是需要给出一个足以支撑其数据中心资本支出的投资估值。" 这位曾出演《正义联盟》、主演《消失的爱人》的演员指出，纵观历史，新技术的普及进程向来"缓慢"且循序渐进。 他表示，科技企业为了合理化自身的巨额投入，纷纷承诺将开发出远超现有水平的新一代人工智能模型；但现实是，每一代新模型的性 能仅有小幅提升，运行所需的电力与数据量却呈指数级增长。 "本・阿弗莱克显然是个聪明人。"伯里于上周末在社交平台X上发文称，"所以他的这番表态并不让我意外，听起来既耳熟又切中要害。" 英雄所见略同：阿弗莱克力挺伯里的AI批判 在 ...

Group 1 - The Freedom Cash Flow ETF (159201) experienced a slight decline of 0.47% in early trading on January 20, with leading stocks such as Satellite Chemical, Kuka Home, and Fostda rising over 4% [1] - Over the past 10 trading days, the Freedom Cash Flow ETF (159201) has seen net inflows on 8 occasions, totaling over 628 million yuan [1] - The latest share price of the Freedom Cash Flow ETF (159201) reached 77.50, with a total scale of 98.34 billion yuan, both marking new highs since its inception [1] Group 2 - GF Securities predicts that by 2025, China's economic resilience will exceed market expectations, and the AI industry will enter a new phase, leading to a favorable performance in the equity market despite market volatility due to a complex international environment [1] - Looking ahead to 2026, global economic easing is expected to continue, with artificial intelligence unlikely to bubble, laying the foundation for an equity bull market; however, both domestic and international equity valuations are already high, indicating a shift in the A-share market towards a phase driven primarily by profit improvement rather than valuation expansion [1] - After the valuation recovery in 2025, the A-share market is anticipated to enter a "reasonable range," with the upward momentum in 2026 relying more on substantial improvements in corporate earnings [1] Group 3 - The Freedom Cash Flow ETF (159201) and its linked funds (A: 023917; C: 023918) closely track the National Securities Freedom Cash Flow Index, addressing the shortcomings of traditional dividend strategies by focusing on endogenous growth capacity and emphasizing financial health and sustainability [2] - This fund strategy aligns well with the needs of investors seeking long-term growth and capital appreciation [2] - The fund management fee is set at an annual rate of 0.15%, and the custody fee at 0.05%, both representing the lowest fee levels in the market, maximizing benefits for investors [2]

Group 1 - The semiconductor chip stocks experienced a rally, with the Shanghai Stock Exchange Sci-Tech Innovation Board chip index rising by 0.70% as of 09:54 on January 20, 2026, driven by significant gains in individual stocks such as Baiwei Storage (up 7.42%) and Longxin Zhongke (up 5.62%) [1] - The DRAM market continues to face supply tightness, with the price of mainstream DDR4 models increasing by nearly 10% week-over-week, primarily due to suppliers and traders adopting a strategy of withholding sales and stockpiling inventory [1] - Micron reported that AI demand now accounts for 50%-60% of the DRAM market, serving as the main driver for the sustained increase in storage chip prices [1] - The enterprise SSD pricing is also under upward pressure, with some manufacturers like SanDisk requiring customers to make full prepayments to secure NAND allocations for the coming years [1] Group 2 - High-performance computing (HPC) chips have become the core engine driving TSMC's advanced process business growth, with HPC revenue accounting for 55% of TSMC's total revenue, significantly surpassing the smartphone segment at 32% [1] - The HPC business continues to show strong growth resilience compared to the seasonal fluctuations of the smartphone business, suggesting a robust investment opportunity in the HPC chip supply chain, particularly in domestic GPU and advanced process foundry sectors [1] - As of December 31, 2025, the top ten weighted stocks in the Sci-Tech Innovation Board chip index include SMIC, Haiguang Information, and Cambrian, collectively accounting for 57.76% of the index [2] - The Sci-Tech Chip ETF (588200) tracks the Sci-Tech Innovation Board chip index, providing a convenient tool for investors to gain exposure to the domestic chip sector [2] - Investors without stock accounts can access the domestic chip investment opportunities through the Sci-Tech Chip ETF linked fund (017470) [2]

Core Viewpoint - Samsung Electronics and SK Hynix are expected to reduce NAND flash production this year, which may lead to a supply shortage and price increases across various sectors, including AI, servers, personal computers, and mobile devices [1][2]. Group 1: NAND Flash Market Dynamics - Samsung Electronics has slightly lowered its NAND flash wafer production forecast from 4.9 million last year to 4.68 million this year, following a previous reduction due to anticipated declines in NAND profitability [1]. - SK Hynix's NAND flash production is also expected to decrease from 1.9 million wafers last year to 1.7 million this year [1]. - The demand for NAND flash is surging due to the rise of AI, with major suppliers' adjustments potentially exacerbating supply shortages across all sectors [2]. Group 2: Impact of AI on NAND Flash Demand - Nvidia's next-generation AI accelerator, Vera Rubin, is set to have a solid-state drive (SSD) capacity of 1152TB, significantly increasing demand for NAND flash [2]. - The expected shipment of Vera Rubin is 30,000 units this year and 100,000 units next year, which will create additional demand of 34.6 million TB and 115.2 million TB by 2026 and 2027, respectively [2]. Group 3: Production Strategy and Market Position - Samsung and SK Hynix are prioritizing DRAM investments over NAND flash due to lower profitability, leading to intentional production cuts [3]. - China's Yangtze Memory Technologies has been steadily increasing its NAND flash production, indicating a strengthening market position and a shift in focus towards server and enterprise applications [3]. Group 4: Price Predictions and Market Trends - TrendForce predicts that NAND flash contract prices will rise by 33% to 38% in the first quarter, reflecting a conservative production strategy from major suppliers [3]. - IDC forecasts a 17% growth in NAND flash supply this year, which is below the average growth rate in recent years [3]. Group 5: HBM Production Expansion - Samsung and SK Hynix are increasing their semiconductor production capacity to meet the demand for various chips, including HBM and DDR [4]. - Samsung's HBM capacity is expected to grow by 50% by 2026 to fulfill large orders from Nvidia [4]. Group 6: Investment in New Facilities - Samsung plans to invest 60 trillion KRW (approximately 41.5 billion USD) in a new factory in Pyeongtaek, which is expected to begin production in 2028 [5]. - SK Hynix is investing over 20 trillion KRW in the M15X factory, which will include two clean rooms for chip production [7].

16 January 2026 Asia Quant Strategy & Asia Semis & Internet Asia Tech in 2026: Near-term momentum intact but broaden the exposure Rupal Agarwal +65 6326 7641 rupal.agarwal@bernsteinsg.com Mark Li +852 2123 2645 mark.li@bernsteinsg.com Robin Zhu +852 2123 2659 robin.zhu@bernsteinsg.com Cheng Zhang, CFA, CQF +852 2123 2636 cheng.zhang@bernsteinsg.com Edward Hou, CFA +852 2123 2623 edward.hou@bernsteinsg.com Charles Gou +852 2123 2618 charles.gou@bernsteinsg.com Min-Joo Kang +852 2123 2644 minjoo.kang@bernstei ...

Core Insights - The core focus of the discussions at the World Economic Forum is on agriculture as a critical area for innovation and stability, particularly in the context of global economic slowdown, climate risks, and geopolitical uncertainties [1] Group 1: AI in Agriculture - AI in agriculture is not hindered by technology but is approached with caution due to the complexity and sensitivity of real-world production systems [2] - The main challenges in agricultural AI differ by market; in developed markets, issues include data fragmentation and infrastructure costs, while in emerging economies, the usability of technology for smallholders is paramount [2] - The acceptance of new technologies in agriculture is slower compared to other industries due to the high stakes involved, where any misstep can directly impact farmers' livelihoods [2] Group 2: Shift from Production to Resilience - The importance of agricultural AI is increasingly linked to system resilience rather than just production volume, as agriculture contributes significantly to greenhouse gas emissions and environmental degradation [4] - Advanced data analysis and decision support technologies are beginning to reconcile the trade-off between increasing yield and reducing environmental impact [5] - The definition of food security is evolving from mere availability to stability, with technology playing a role in mitigating the impacts of extreme weather and geopolitical conflicts on food markets [5] Group 3: China's Role in Agricultural AI - China is viewed as a significant case study for agricultural AI practices, emphasizing a systemic approach that integrates technology, breeding, chemicals, machinery, and data [6] - The implementation of AI in China focuses on practical applications such as pest identification and weather risk assessment, making it relevant to farmers' daily decisions [6] - China's agricultural digitalization offers a model for other emerging markets, showcasing a pathway for data and AI to transition from pilot projects to everyday decision-making [6]

"既往未来—— 小西天文物撷珍与悬塑艺术特展" ■展期：至2026年5月8日 这一幕，靠的是 毫米级精度的数字化采集 和超拟真数字模型。 ■地点：国家典籍博物馆第三、四展厅 ■票价：正价票98元（获取购票方式请查看国家典籍博物馆微信公众号） 人在北京，眼前却是 "高清重制版" 小西天大雄宝殿—— 工艺特征与风格范式， 在遵循文物原始样貌的前提下， 增强细节辨识度与视觉清晰度， 这是怎么做到的呢？ 技术团队利用闭馆时间， 扫描文物细节，实现 毫厘毕现的数字化复刻。 对于已模糊不清的细节， 团队通过AI算法， 比对同时期彩绘标本的 最大程度接近1:1超写实还原。 来源：北京日报客户端 ...